Cardiology Topics

1. Echocardiographic assessment of left atrial strain as an early predictor of diastolic dysfunction in hypertensive patients.
2. Speckle-tracking echocardiography for early detection of subclinical cardiomyopathy in type 2 diabetes.
3. Comparative study of heart failure with preserved vs reduced ejection fraction in elderly patients: clinical, biochemical, and echocardiographic correlates.
4. Association of lipoprotein(a) with premature coronary artery disease in young Indian adults.
5. Role of serum uric acid in predicting resistant hypertension and its correlation with left ventricular hypertrophy.
6. Prognostic value of fragmented QRS on ECG in patients with dilated cardiomyopathy.
7. Cardiovascular manifestations in hypothyroidism: focus on right ventricular function and pulmonary hypertension.
8. Association between high-sensitivity troponin T and coronary microvascular dysfunction in diabetics.
9. Prevalence and clinical profile of arrhythmias in acute myocardial infarction with emphasis on early predictors of ventricular tachyarrhythmias.
10. Machine learning-based risk stratification in acute coronary syndrome using clinical and echocardiographic variables.
11. Evaluation of non-traditional lipid ratios (TG/HDL-C, ApoB/ApoA1) in newly diagnosed hypertension.
12. Heart failure with preserved versus reduced ejection fraction in diabetics: a comparative echocardiographic study.
13. Machine learning models to predict adverse outcomes in acute coronary syndrome using clinical and echocardiographic variables.
14. Role of speckle-tracking echocardiography in detection of subclinical cardiomyopathy in type 2 diabetes.
15. Microvascular dysfunction in diabetic patients assessed by coronary flow reserve on echocardiography.
16. Electrocardiographic predictors of malignant ventricular arrhythmias in dilated cardiomyopathy.
17. Prevalence and determinants of left atrial strain abnormalities in hypertensive heart disease.
18. Association of lipoprotein(a) with premature coronary artery disease in young Indian adults.
19. Clinical and genetic predictors of statin intolerance in Indian population.
20. Evaluation of high-sensitivity cardiac troponin as a marker of subclinical cardiotoxicity in patients on chemotherapy
21. Left atrial strain as an integrated marker of metabolic syndrome severity- combining echocardiography with biochemical risk factors.
22. Lipoprotein(a), hs-CRP and carotid intima-media thickness: a triad for risk prediction in premature coronary artery disease.
23. Impact of thyroid dysfunction on cardiac remodeling in hypertensive patients- an echo-biochemical study.
24. Correlation of serum uric acid with left ventricular diastolic dysfunction and arterial stiffness in essential hypertension.
25. Machine learning algorithms using lipid ratios and echocardiographic parameters to predict adverse cardiac events.
26. Role of vitamin D deficiency in resistant hypertension and left ventricular hypertrophy.
27. Clinical profile and outcomes of atrial fibrillation in diabetic vs non-diabetic patients
28. Association of HbA1c levels with left ventricular diastolic dysfunction on echocardiography
29. Study of P-wave dispersion as a predictor of atrial fibrillation
30. Role of serum uric acid in patients with atrial fibrillation
31. ECG changes in patients with early diabetic cardiomyopathy
32. Prevalence of silent atrial fibrillation using Holter monitoring in high-risk patients
33. Correlation of BMI with severity of diastolic dysfunction
34. Study of NT-proBNP levels in predicting heart failure severity
35. Clinical and etiological profile of young patients (<45 years) with atrial fibrillation
36. Drug compliance and its impact on outcomes in atrial fibrillation patients
37. Prevalence of electrolyte abnormalities in patients presenting with arrhythmias
38. Study of CHA₂DS₂-VASc score correlation with actual stroke events
39. Assessment of awareness about anticoagulation therapy in AF patients
40. Echocardiographic assessment of left atrial size as predictor of atrial fibrillation
41. Clinical profile and outcomes of patients with BRASH syndrome
42. Study of hypertension as a risk factor for atrial fibrillation in OPD patients
43. Correlation of duration of diabetes with cardiac structural changes
44. Study of lipid profile abnormalities in patients with cardiomyopathy
45. Short-term outcomes of patients undergoing valve replacement surgery
46. Awareness and willingness for organ donation among healthcare workers
47. Study of dental health status in patients with cardiovascular disease
48. Correlation of resting heart rate with cardiovascular risk factors
49. Prevalence of anemia in patients with heart failure
50. Study of QT interval changes in diabetic patients
51. Clinical profile of patients with hypertrophic cardiomyopathy in a tertiary center
52. Comparison of high-intensity vs moderate-intensity statins in achieving LDL targets
53. Study of statin adherence and its impact on lipid control
54. Prevalence of statin intolerance in patients attending cardiology OPD
55. Effect of statins on liver enzymes in routine clinical practice
56. Study of muscle-related side effects in patients on statin therapy
57. Correlation of LDL levels with severity of coronary artery disease
58. Evaluation of goal-directed lipid therapy as per current guidelines
59. Role of statins in primary vs secondary prevention of cardiovascular disease
60. Effect of statins on HDL and triglyceride levels
61. Study of prescribing patterns of statins in a tertiary care hospital
62. Awareness and knowledge about statin therapy among patients with dyslipidemia
63. Impact of combination therapy (statin + ezetimibe) vs statin alone
64. Time to achieve target LDL levels after initiation of statin therapy
65. Study of lipid profile changes in diabetic patients on statins
66. Association between statin dose and reduction in cardiovascular events
67. Evaluation of residual cardiovascular risk despite statin therapy
68. Gender differences in response to statin therapy
69. Study of discontinuation rates of statins and reasons for stopping
70. Correlation between baseline lipid levels and response to statins